HIV/AIDS Prognosis
CD4+ levels related to AIDS or death than latest viral load levels in patients on HAART
Published in AIDS Weekly, November 21st, 2005
According to recent research published in the journal HIV Clinical Trials, "The comparative prognostic importance of latest plasma HIV RNA levels (viral loads) and CD4+ cell counts among patients prescribed highly active antiretroviral therapy (HAART) has not been well characterized.
"We assessed the prognostic value of latest CD4+ cell counts and latest viral loads for progression to AIDS or death and explored their interaction among 432 HIV-infected persons with advanced HIV who were prescribed a protease inhibitor (PI)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-11-21)
More Articles from AIDS Weekly
- Disease Control
Nonbrothel based female sex workers at higher risk of HIV infection than brothel workers - HIV/AIDS Adverse Drug Reaction
Cumulative HAART exposure increases risk of side effect-related morbidity in children - HIV/AIDS Drug Development
Mycophenolic acid inhibits syncytium formation accompanied by reduction of HIV- gp120 expression - HIV/AIDS Epidemiology
HLA class II alleles associated with HIV-1 pathogenesis in Botswana - Business & Finance
Genomics company reports first quarter net loss of $16.7 million - Clinical Trials
HIV drug maker posts loss of $0.36 per share - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
